{"log_id": 4212265177432513696, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.000513, "average": 0.969252, "min": 0.945132}, "location": {"width": 66, "top": 173, "height": 20, "left": 166}, "words": "儿升高"}, {"probability": {"variance": 0, "average": 0.980207, "min": 0.980207}, "location": {"width": 16, "top": 174, "height": 17, "left": 597}, "words": "0"}, {"probability": {"variance": 0.057947, "average": 0.72278, "min": 0.377409}, "location": {"width": 102, "top": 213, "height": 22, "left": 166}, "words": "腹糖高"}, {"probability": {"variance": 0.030211, "average": 0.813926, "min": 0.548105}, "location": {"width": 109, "top": 253, "height": 22, "left": 160}, "words": "细胞少莊"}, {"probability": {"variance": 0.030676, "average": 0.78385, "min": 0.484465}, "location": {"width": 155, "top": 293, "height": 20, "left": 165}, "words": "白细胞(WBCj减少鞋"}, {"probability": {"variance": 0.015639, "average": 0.867777, "min": 0.692559}, "location": {"width": 31, "top": 290, "height": 19, "left": 889}, "words": "2.0"}, {"probability": {"variance": 5.6e-05, "average": 0.994498, "min": 0.979588}, "location": {"width": 99, "top": 370, "height": 25, "left": 165}, "words": "上市后报告"}, {"probability": {"variance": 2.3e-05, "average": 0.997552, "min": 0.982918}, "location": {"width": 230, "top": 408, "height": 25, "left": 204}, "words": "上市后发现以下不良反应"}, {"probability": {"variance": 0.003245, "average": 0.969495, "min": 0.821992}, "location": {"width": 238, "top": 446, "height": 28, "left": 212}, "words": "非常罕见:泪管狭窄NOS"}, {"probability": {"variance": 0.000471, "average": 0.990961, "min": 0.902485}, "location": {"width": 688, "top": 483, "height": 28, "left": 210}, "words": "非常罕见:临床试验和上市后报告中有肝功能衰竭、胆汁淤积型肝炎的报道"}, {"probability": {"variance": 0, "average": 0.998612, "min": 0.998188}, "location": {"width": 74, "top": 526, "height": 25, "left": 168}, "words": "【禁忌】"}, {"probability": {"variance": 0.005653, "average": 0.969304, "min": 0.70932}, "location": {"width": 375, "top": 563, "height": 27, "left": 206}, "words": "已知对卡培他滨或其任何成分过敏者禁用"}, {"probability": {"variance": 0.000897, "average": 0.988268, "min": 0.861411}, "location": {"width": 710, "top": 598, "height": 32, "left": 204}, "words": "既往对氟尿嘧啶有严重,非预期的反应或已知对氟嘧啶过敏患者禁用卡培他滨"}, {"probability": {"variance": 0.006189, "average": 0.966863, "min": 0.594223}, "location": {"width": 743, "top": 637, "height": 31, "left": 204}, "words": "同其他氟尿嘧啶药物一样,卡培他滨禁用于已知二氢嘧啶脱氢酶(DPD)缺陷的患者"}, {"probability": {"variance": 0.009643, "average": 0.957176, "min": 0.469721}, "location": {"width": 721, "top": 676, "height": 32, "left": 206}, "words": "卡培他滨不应与索立夫定或其类似物如溴夫定)同时给药(见【药物相互作用】)"}, {"probability": {"variance": 0.003273, "average": 0.978007, "min": 0.705198}, "location": {"width": 572, "top": 717, "height": 28, "left": 206}, "words": "卡培他滨禁用于严重肾功能损伤患者(肌酐清除率低于30ml/分)"}, {"probability": {"variance": 0.000646, "average": 0.988657, "min": 0.867072}, "location": {"width": 647, "top": 753, "height": 33, "left": 206}, "words": "联合化疗时,如存在任一联合药物相关的禁忌症,则应避免使用该药物"}, {"probability": {"variance": 0.00012, "average": 0.991948, "min": 0.960851}, "location": {"width": 479, "top": 795, "height": 29, "left": 207}, "words": "对顺铂的禁忌症同样适用于卡培他滨和顺铂联合治疗"}, {"probability": {"variance": 0, "average": 0.999351, "min": 0.998341}, "location": {"width": 113, "top": 837, "height": 25, "left": 173}, "words": "【注意事项】"}, {"probability": {"variance": 0.00619, "average": 0.981954, "min": 0.515675}, "location": {"width": 767, "top": 871, "height": 33, "left": 219}, "words": "腹泻:卡培他滨可引起腹泻,有时比较严重。对于出现严重腹泻的患者应给予密切监"}, {"probability": {"variance": 0.005204, "average": 0.979718, "min": 0.564984}, "location": {"width": 821, "top": 911, "height": 32, "left": 166}, "words": "护,若患者开始出现脱水,应立即补充液体和电解质。在适当的情况下,应及早开始使用标"}, {"probability": {"variance": 0.011265, "average": 0.945964, "min": 0.574901}, "location": {"width": 660, "top": 950, "height": 34, "left": 168}, "words": "准止泻治疗药物(如洛哌丁胺)。必要时需降低给药剂量(见【用法用量】)"}, {"probability": {"variance": 0.009562, "average": 0.975889, "min": 0.405137}, "location": {"width": 767, "top": 988, "height": 34, "left": 222}, "words": "脱水:必须预防脱水,并且在脱水出现时及时纠正。患者出现厌食、虚弱、恶心、"}, {"probability": {"variance": 0.004638, "average": 0.983015, "min": 0.563077}, "location": {"width": 801, "top": 1028, "height": 33, "left": 168}, "words": "吐或腹泻时早期啡可出现脱水。当出现2级(或以上)脱水症状时,必须立即停止本品的治疗"}, {"probability": {"variance": 0.005977, "average": 0.982282, "min": 0.51118}, "location": {"width": 819, "top": 1067, "height": 34, "left": 170}, "words": "同时纠正脱水。直到患者脱水症状消失,且导致脱水的直接原因被纠正和控制后,才可以重"}, {"probability": {"variance": 1.2e-05, "average": 0.997815, "min": 0.98226}, "location": {"width": 542, "top": 1108, "height": 32, "left": 171}, "words": "新开始本品治疗。针对此不良事件,调整给药剂量是必要的"}, {"probability": {"variance": 0.006636, "average": 0.973994, "min": 0.643526}, "location": {"width": 781, "top": 1145, "height": 34, "left": 211}, "words": "已观察到的卡培他滨的心脏毒性与氟尿嘧啶药物类似,包括心肌梗死、心绞痛、心律不"}, {"probability": {"variance": 0.00032, "average": 0.993595, "min": 0.898175}, "location": {"width": 820, "top": 1184, "height": 33, "left": 171}, "words": "齐、心脏停搏、心脏功能衰竭和心电图改变。既往有冠状动脉病史的患者中这些不良事件可"}, {"probability": {"variance": 1e-06, "average": 0.998834, "min": 0.99691}, "location": {"width": 86, "top": 1229, "height": 25, "left": 172}, "words": "能更常见"}, {"probability": {"variance": 0.000225, "average": 0.991482, "min": 0.93468}, "location": {"width": 778, "top": 1262, "height": 33, "left": 214}, "words": "既往有因二氢嘧啶脱氢酶缺乏(DPD)引起的5-氟尿嘧啶相关的罕见、难以预料的严重毒"}, {"probability": {"variance": 0.000836, "average": 0.990511, "min": 0.823737}, "location": {"width": 818, "top": 1301, "height": 34, "left": 174}, "words": "性(例如口腔炎症、腹泻、嗜中性粒细胞减少症和神经毒性)发生。因此无法排除DPD水平"}, {"probability": {"variance": 6e-05, "average": 0.996929, "min": 0.959693}, "location": {"width": 587, "top": 1343, "height": 29, "left": 173}, "words": "降低与5-氟尿嘧啶潜在致死性毒性效应增强之间存在关联的可能"}, {"probability": {"variance": 0.000226, "average": 0.993369, "min": 0.931235}, "location": {"width": 763, "top": 1381, "height": 33, "left": 218}, "words": "卡培他滨可引起手足综合征(手掌足底红肿疼痛或化疗引起肢端红斑),一种皮肤毒性"}, {"probability": {"variance": 0.001077, "average": 0.990117, "min": 0.811905}, "location": {"width": 821, "top": 1423, "height": 28, "left": 173}, "words": "转移性肿瘤患者接受卡培他滨单药治疗,手足综合征出现的中位时间为79天(范围从11到"}, {"probability": {"variance": 0.000336, "average": 0.992223, "min": 0.928134}, "location": {"width": 271, "top": 1465, "height": 26, "left": 180}, "words": "60天),严重程度为1到3级"}, {"probability": {"variance": 0.011104, "average": 0.965304, "min": 0.586233}, "location": {"width": 755, "top": 1500, "height": 30, "left": 239}, "words": "级手足综合征定义为出现下列任一现象:手和/或足的麻木、感觉迟钝/感觉异常、麻"}], "language": 3}